News About: Pharm. Industry
KFDA approves simvastatin CR’s intake anytime
Hanmi Pharm says it has received approval from the Korea Food and Drug Administration to administer simvastatin controlled release (CR) tablet without restriction in the morning or at night.
For simvastatin, the ev...
Multinationals agonizing over 2010 business plan
A majority of multinational companies in Korea are still struggling to finalize their business plans for the new year, according to industry observers.
The government’s unpredictable drug pricing policies have led...
Local clinical tests focus on development of new anticancer drugs
Domestic and foreign drug makers are conducting their clinical trials which are centered on the development of new anticancer medicines, according to the Korea Food and Drug Administration.
The drug agency said on ...
Leading and mid-sized pharmaceutical firms spend over 3 billion in 3Q ads
Details of each drug company’s spending in OTC advertisement revealed recently show that the country’s 24 leading and mid-sized pharmaceutical companies on average spent over 3 billion won of their annual revenue on a...
AstraZeneca to face Crestor generic challenge
The Britain-based AstaZeneca is expected to face a generic challenge to its blockbuster cholesterol drug Crestor (rosuvastatin calcium) by 50 Korean companies.
These local companies are seeking approval to sell a c...
Green Cross to conduct additional clinical trials for flu vaccine
Clinical trials for the H1N1 flu vaccine will be additionally conductedon 63 children aged under 3 years, said local drug maker Green Cross Corporation.
A total of two shots will be injected at a three-week interva...
Local drugmakers anger over incentive system for low-price drugs in hospital
The government’s plan to introduce a controversial incentive system for low-price drugs in hospital has invited criticism from domestic drug makers.
Aimed at providing cheaper drugs for patients, the government is ...
Thermometers in great demand
The H1N1 flu virus scare has sent the demand for hygienic products soaring since the nation's first death was reported on August 15.
Along with protective masks and hand sanitizers, the sales of thermometers are a...
KFDA mulls BGMP guideline to ‘Joins’ generics
The Korea Food and Drug Administration is considering implementing the bulk good manufacturing practice to the generic versions of Joins, an arthritis drug developed by SK Chemicals Co.
In an information session on...
Hanall announces supply agreement with Chinese firm over H1N1 vaccine
In an effort to secure an adequate supply of the vaccine, Korea's Hanall Pharmaceutical Co. signed a memorandum of understanding with Ealong Biotech Ltd., a Chinese vaccine maker, on November 11 to purchase as many as...
